{"id":"NCT04333420","sponsor":"InflaRx GmbH","briefTitle":"Randomized, Controlled Study of IFX-1 in Patients With Severe COVID-19 Pneumonia","officialTitle":"A Pragmatic Adaptive Randomized, Controlled Phase II/III Multicenter Study of IFX-1 in Patients With Severe COVID-19 Pneumonia","status":"COMPLETED","phase":"PHASE2","dates":{"start":"2020-03-31","primaryCompletion":"2021-10-31","completion":"2021-12-01","firstPosted":"2020-04-03","resultsPosted":"2023-06-05","lastUpdate":"2023-06-05"},"enrollment":399,"design":{"allocation":"RANDOMIZED","model":"PARALLEL","masking":"DOUBLE","primaryPurpose":"TREATMENT"},"conditions":["Severe COVID-19 Pneumonia"],"interventions":[{"type":"DRUG","name":"IFX-1 + BSC","otherNames":["Vilobelimab + Best Supportive Care"]},{"type":"DRUG","name":"BSC","otherNames":["Best Supportive Care"]},{"type":"DRUG","name":"IFX-1 + SOC","otherNames":["Vilobelimab + Standard of Care"]},{"type":"DRUG","name":"Placebo + SOC","otherNames":["Placebo + Standard of Care"]}],"arms":[{"label":"Phase II: IFX-1 + BSC","type":"EXPERIMENTAL"},{"label":"Phase II: BSC","type":"OTHER"},{"label":"Phase III: IFX-1 + SOC","type":"EXPERIMENTAL"},{"label":"Phase III: Placebo + SOC","type":"PLACEBO_COMPARATOR"}],"summary":"Phase II \\& Phase III:\n\nThis is a pragmatic, adaptive, randomized, multicenter phase II/III study evaluating IFX-1 for the treatment of COVID-19 related severe pneumonia. The study consists of two parts: Phase II, an open-label, randomized, 2-arm phase evaluating best supportive care (BSC) + IFX-1 (Arm A) and BSC alone (Arm B); and Phase III, a double-blind, placebo-controlled, randomized phase comparing standard of care (SOC) + IFX-1 (Arm A) versus SOC + placebo-to-match (Arm B)","primaryOutcome":{"measure":"Phase II: Relative Change From Baseline in Oxygenation Index in Supine Position at Day 5 (FAS)","timeFrame":"Baseline and Day 5","effectByArm":[{"arm":"Phase II: IFX-1 + BSC","deltaMin":15.5,"sd":null},{"arm":"Phase II: BSC","deltaMin":31.9,"sd":null}],"pValues":[{"comp":"OG000 vs OG001","p":"0.3677"}]},"eligibility":{"minAge":"18 Years","sex":"ALL","healthyVolunteers":false,"inclusionCount":3,"exclusionCount":9},"locations":{"siteCount":48,"countries":["Belgium","Brazil","France","Germany","Mexico","Netherlands","Peru","Russia","South Africa"]},"refs":{"pmids":["38943192","37332066","36087611","35029045","34473343","33015643"],"seeAlso":[]},"adverseEventsSummary":{"seriousAny":{"events":9,"n":15},"commonTop":["Acute kidney injury","Pneumonia","Pyrexia","Atrial fibrillation","Anaemia"]}}